Form 4: Twist Bioscience SVP of Human Resources, Paula Green, Sells Shares to Cover Tax Obligations
SEC Form 4 Filing
Paula Green, SVP of Human Resources at Twist Bioscience Corp, sold 282 shares of common stock on December 20, 2024, to cover tax withholding obligations related to vesting Restricted Stock Units.
Summary
- On December 20, 2024, Paula Green, the SVP of Human Resources at Twist Bioscience Corp, sold 282 shares of the company's common stock.
- The sale was executed at a price of $44.903 per share.
- The purpose of this transaction was to cover tax withholding obligations associated with the vesting of Restricted Stock Units.
- Following the transaction, Paula Green still beneficially owns 133,433 shares of Twist Bioscience Corp.
- The sale was mandated by Twist Bioscience's equity incentive plans, requiring tax withholding obligations to be funded through a 'sell to cover' transaction.
Sentiment
Score: 6
Explanation: Neutral sentiment as the transaction is a routine sale to cover tax obligations and doesn't indicate a change in the executive's confidence in the company.
Industry Context
This is a routine transaction related to executive compensation and tax obligations. It is common for executives to sell shares to cover taxes when stock options or restricted stock units vest. It does not necessarily indicate a negative outlook on the company.
Comparison to Industry Standards
- Executive stock sales to cover taxes are a common practice across publicly traded companies.
- Companies like Illumina, Inc. (ILMN) and Danaher Corporation (DHR) also see similar transactions from their executives regularly.
- The number of shares sold is relatively small compared to the total holdings, which is typical in these types of transactions.
Stakeholder Impact
- The transaction is unlikely to have a significant impact on shareholders as it is a small percentage of the total outstanding shares and is related to tax obligations.
Key Dates
| Date | Description |
|---|---|
| 12/20/2024 | Date of the stock sale transaction. |
| 12/26/2024 | Date of signature for the SEC Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.